Skip to main content
. 2023 Dec 6;14:1267503. doi: 10.3389/fendo.2023.1267503

Table 1.

Patients’ characteristics on baseline.

Characteristics Beinaglutide (n=67) Control (n=67) p value*
Age (years) 52.1 ± 9.2 51.8 ± 8.3 0.68
FBG (mmol/L) 7.47 ± 1.77 7.86 ± 2.16 0.25
2hBG (mmol/L) 12.94 ± 2.23 13.26 ± 2.63 0.92
HbA1c% 9.45 (7.70,11.22) 9.60 (8.10,11.91) 0.29
LBGI 2.62 ± 1.81 2.71 ± 1.20 0.54
Weight (kg) 84.34 ± 13.86 83.12 ± 16.09 0.64
BMI (kg/m2) 27.08 ± 3.64 26.87 ± 2.94 0.71
WC (cm) 98.15 ± 9.67 97.44 ± 8.29 0.65
SFA (cm2) 175.96 ± 37.47 171.86 ± 39.49 0.25
ALT (U/L) 26.67 (19.96,37.15) 23.00 (17.00,37.12) 0.22
AST (U/L) 26.57 (19.00,35.00) 23.00 (17.00,33.00) 0.24
Cr (mmol/L) 70.82 ± 21.43 69.16 ± 20.68 0.65
UA (mmol/L) 364.96 ± 87.96 357.29 ± 91.75 0.26
Non-fasting TG (mmol/L) 2.74 ± 5.96 2.68 ± 5.61 0.96
TC (mmol/L) 4.96 (4.33,6.10) 4.96 (4.10,6.47) 0.71
HDL-C (mmol/L) 1.00 ± 0.24 1.04 ± 0.22 0.26
LDL-C (mmol/L) 2.93 ± 0.85 2.85 ± 0.84 0.61
TG(mmol/L) 2.12 (1.23,2.91) 2.24 (1.23,3.08) 0.75
ApoB (mg/dL) 1.01 ± 0.41 1.02 ± 0.36 0.89
FFA (nmol/L) 0.42 ± 0.20 0.39 ± 0.17 0.43
HOMA-IR 2.40 (1.16,3.23) 2.41 (1.19,3.19) 0.90

*p<0.05.